Enhertu for thousands of British women with incurable breast cancer in NHS from Thursday

Around a thousand women per year in England with advanced HER2-low breast cancer will gain access to the life-extending drug Enhertu through the NHS from Thursday. This became possible following successful government negotiations with the drug manufacturer over its price. The drug was previously unavailable publicly due to high costs.